Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study

Sponsor
Seoul National University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02553109
Collaborator
Seoul National University Bundang Hospital (Other), SMG-SNU Boramae Medical Center (Other), DongGuk University (Other), Inje University (Other), Jeju National University Hospital (Other), KangWon National University Hospital (Other), Gyeongsang National University Hospital (Other), Soonchunhyang University Hospital (Other), Samsung Medical Center (Other), Asan Medical Center (Other)
682
8
107
85.3
0.8

Study Details

Study Description

Brief Summary

The optimal consensus concerning treatment of incidental small paraclinoid unruptured intracranial aneurysms (UIAs) remains controversial. The aim of this prospective study is to reveal the natural history of small paraclinoid UIAs with the goal of informing the treatment plan.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A prospective observational study will be conducted in 13 Korean centers enrolling a consecutive series of 645 patients with small paraclinoid unruptured intracranial aneurysms (UIAs) from 2015 to 2017.

    The investigators defined the cohort population as adults(20 years old or more) with small (less than 5mm) unruptured paraclinoid aneurysm. To determine the growth rate and risk factors, the angiographic features based on MRA or CTA(ex) size, arterial relationship, multiplicity)and the clinical characteristics (ex) age, hypertension (HTN), diabetes mellitus(DM), Hyperlipidemia, smoking) are recorded at initial visit, 1 year, 2years, 3years, and 5years.

    The cumulative risk and the risk factors of aneurysmal rupture and growth will be analysed.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    682 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Risk of Rupture or Growth in Patients With Small Unruptured Paraclinoid Aneurysm: Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study
    Study Start Date :
    Jan 1, 2015
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    small unruptured paraclinoid aneurysm

    Patients with newly diagnosed, small (less than 5mm) unruptured paraclinoid aneurysms who will visit one of the study centers during the period from January 2015 to February 2017. Patients would be eligible for enrollment if they were 20 years of age or older and had an unruptured paraclinoid aneurysm that is less than 5 mm in the largest dimension. All patients who would visit a study center during the enrollment period and meet these criteria will be asked to join the study. The cohort will consists of patients who agree to participate. Target population of this study is 645 aneurysms.

    Outcome Measures

    Primary Outcome Measures

    1. Number of increased maximal diameter of enrolled paraclinoid aneurysms on follow up MRA or CTA [within 5years after enrollment]

      If, the maximal diameter(in mm) of aneurysm which is measured by 1 neurosurgeon and 1 neuroradiologist on follow up MRA or CTA (1,2,3,5 year follow up) is 1.5 times bigger than on initial MRA or CTA, investigators will decide that the aneurysm is increased.

    2. Number of rupture of enrolled paraclinoid aneurysms [within 5years after enrollment]

      annual rupture rate

    Secondary Outcome Measures

    1. Mortality rate of enrolled patients(related to rupture of aneurysm or not) [within 5years after enrollment]

      death due to ruptured aneurysm

    2. Number of participants with worsened modified Rankin scale score [within 5years after enrollment]

      from 0(No symptom at all) to 6(Dead)

    3. Number of participants with worsened Karnofsky Performance Status scale [within 5years after enrollment]

      from 0(Dead) to 100(Normal)

    4. Treatment(due to growth or rupture) rate of enrolled aneurysms [within 5years after enrollment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with newly diagnosed small unruptured paraclinoid aneurysms who agreed to participate.

    • 20years old or more

    • less than 5mm in maximum diameter

    • neurological status of patients should be satisfied with less than modified Rankin score 2 or more than 70 in Karnofsky performance score

    Exclusion Criteria:
    • patients had previous subarachnoid hemorrhage that could be related to the rupture of paraclinoid aneurysm.

    • traumatic, infectious or dissecting aneurysms

    • fusiform aneurysms

    • aneurysms that related to other vascular disease or brain tumor

    • aneurysm that associated with the atherosclerotic change of a parent artery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Gyeongsang National University Hospital Jinju Gyeongsangnam-do Korea, Republic of
    2 Sungkyunkwan University Samsung Medical center Seoul Kangnam Korea, Republic of 06351
    3 KangWon National University Hospital Chuncheon Kangwon Korea, Republic of
    4 DongGuk University Ilsan Kyungkido Korea, Republic of
    5 Seoul National University Bundang Hospital Seongnam-si Kyungkido Korea, Republic of 13620
    6 Seoul National University Hospital Seoul Korea, Republic of
    7 SMG-SNU Boramae Medical Center Seoul Korea, Republic of
    8 Soonchunhyang University Hospital - Seoul Seoul Korea, Republic of

    Sponsors and Collaborators

    • Seoul National University Hospital
    • Seoul National University Bundang Hospital
    • SMG-SNU Boramae Medical Center
    • DongGuk University
    • Inje University
    • Jeju National University Hospital
    • KangWon National University Hospital
    • Gyeongsang National University Hospital
    • Soonchunhyang University Hospital
    • Samsung Medical Center
    • Asan Medical Center

    Investigators

    • Principal Investigator: Jeong Eun Kim, MD. PhD., Seoul National University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jeong Eun Kim, Professor, Seoul National University Hospital
    ClinicalTrials.gov Identifier:
    NCT02553109
    Other Study ID Numbers:
    • SNUH-001
    First Posted:
    Sep 17, 2015
    Last Update Posted:
    May 12, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Jeong Eun Kim, Professor, Seoul National University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 12, 2022